Alexandria Venture Investments, LLC - Jun 1, 2021 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
10%+ Owner
Signature
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer
Stock symbol
OMIC
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 05:22 PM
Previous filing
May 26, 2021
Next filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common stock Conversion of derivative security $0 +2.65M $0.00 2.65M Jun 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Series A convertible preferred stock Conversion of derivative security -1.8M -100% 0 Jun 1, 2021 Common stock 1.8M Direct F1, F2
transaction OMIC Series B convertible preferred stock Conversion of derivative security -849K -100% 0 Jun 1, 2021 Common stock 849K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Alexandria Venture Investments, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 1 share of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on May 26, 2021, for no additional consideration. The shares had no expiration date.
F2 Not applicable.